Prices plus VAT plus shipping costs
Ready to ship today,
Delivery time appr. 5-8 days
- Order number: 7TM0056A-IC
- Content: 300 µl
- Host: Rabbit
Serine425 (S425) is major phosphorylation site of the Cannabinoid Receptor 1 (CB1). The pS425-CB1 antibody detects phosphorylation in response to agonists. S425 phosphorylation is likely to be involved in efficient ligand sequestration by CB1. The pS425-CB1 antibody can detect phosphorylated CB1 in mouse brain in vivo.
Alternative Names | CB-R, Central Cannabinoid Receptor |
IUPHAR Target ID | 56 |
UniProt ID | P21554(human) P47746(mouse) P20272(rat) |
Immunohistochemistry (IHC) | 1:50 |
Species Reactivity | Human, Mouse, Rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Immunogen | A synthetic phosphopeptide derived from human CB1 around the phosphorylation site of Ser425. |
Form | Liquid |
Purification | Antigen affinity chromatography |
Storage buffer | Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide |
Storage conditions | short-term 4°C, long-term -20°C |
Figure 1. Immunohistochemical Identification of Agonist-induced Serine425 phosphorylation of the Cannabinoid Receptor 1 in mouse brain. Mice were either injected intraperitoneally with vehicle or specific CB1 agonist CP-55940 (0,75 mg/kg bodyweight) for 30 min. Animals were then transcardially perfused, fixed and stained in presence of phosphatase and protease inhibitors. Shown are confocal images of coronal sections stained with the anti-pS425-CB1 antibody (7TM0056A-IC).
Figure 2. Immunohistochemical Identification of Agonist-induced Serine425 phosphorylation of the Cannabinoid Receptor 1 in mouse hippocampus. Mice were either injected intraperitoneally with vehicle or specific CB1 agonist CP-55940 (0,75 mg/kg bodyweight) for 30 min. Animals were then transcardially perfused, fixed and stained in presence of phosphatase and protease inhibitors. Shown are confocal images of sections of hippocampal formation stained with the anti-pS425-CB1 antibody (7TM0056A-IC).
Fritzwanker S, Nagel F, Kliewer A, Stammer V, Schulz S. In situ visualization of opioid and cannabinoid drug effects using phosphosite-specific GPCR antibodies. Commun Biol. 2023 Apr 15;6(1):419. doi: 10.1038/s42003-023-04786-2. PMID: 37061609; PMCID: PMC10105690.